Last reviewed · How we verify
NCT06876103: RCBT-DA
Effectiveness of an Online Religiously-integrated Cognitive Behavioral Therapy-based Intervention on Death Anxiety
NA trial testing Religiously-integrated Cognitive Behavioral Therapy in Death Anxiety in 44 participants. Not yet recruiting.
1 July 2025
Quick facts
| Lead sponsor | Ibn Haldun University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 44 |
| Start date | 1 June 2025 |
| Primary completion | 1 July 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Religiously-integrated Cognitive Behavioral Therapy
- Classical Cognitive Behavioral Therapy
Conditions studied
- Death Anxiety — all drugs for Death Anxiety →
Sponsor
Ibn Haldun University
Who can join
Adults 18 to 65, any sex, with Death Anxiety. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
There has been growing awareness of the importance of death anxiety (DA) in pathological anxiety. DA is defined as a persistent and unreasonable fear of death and thoughts, fears, and emotions associated with the end of life. DA has been suggested as a core fear that underpins the emergence and perseverance of numerous anxiety disorders. However, previous DA-based treatment studies focus on the elderly, the patients, or health professionals who care for the terminally ill. Therefore, there is a need to examine the effect of psychological interventions on DA and current disorder symptoms in a clinical sample through randomized controlled trials. The current study aims to develop a novel Religiously Integrated Cognitive Behavioral Therapy (RCBT)-based intervention on DA in individuals diagnosed with an anxiety disorder and to compare the effectiveness of RCBT-based intervention with classical CBT-based intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06876103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Death Anxiety
Currently open trials in the same condition.
- NCT06957288 — The Effect of Mindfulness-Based Death Psychoeducation Program on Death Awareness and Death Anxiety Levels in Nurses · NA · recruiting
- NCT06991621 — The Effect of Situation Puzzle Games on Nursing Students' Death Anxiety and Meaning in Life · NA · recruiting
Other Ibn Haldun University trials
Trials by the same sponsor.
- NCT07008209 — Comparing the Effectiveness of Reappraisal Strategies in Adult Participants · NA · completed
- NCT06945796 — ACT-ED: Accessibility and Feasibility of an Acceptance and Commitment Therapy (ACT)-Based Eating Disorder Prevention Pro · NA · completed
- NCT06213194 — The Effects of Executive Functions and Social Cognition on Mental Health · NA · completed
- NCT07334769 — Religiously Integrated Cognitive Behavioral Therapy · NA · completed
- NCT06758635 — Online Versions of Single Session Virtual Reality (VR) Therapy and EMDR Flash Therapy on the Treatment of Flying Fear · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06876103 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ibn Haldun University
- Last refreshed: 3 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06876103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing